{
  "fullName": "Shyam Aggarwal",
  "slug": "shyam-aggarwal",
  "title": "MD",
  "specialty": "Cancer Clinical Trials",
  "subSpecialty": null,
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Le Chakka is a 2010 Indian Bengali-language sports comedy drama film co-written and directed by Raj Chakraborty. Produced by Shyam Aggarwal under the banner of Srijan Arts, the screenplay and dialogues of the film were by Padmanabha Dasgupta and Abhimanyu Mukherjee. It stars Dev, Ritwick Chakraborty and Payel Sarkar in lead roles, while Kharaj Mukherjee, Biswajit Chakraborty, Dipankar De, Supriyo Dutta, Laboni Sarkar, Biswanath Basu, Parthasarathi Chakraborty, Pradip Dhar, Prasun Gain, Ritwick Chakraborty and Anindya Banerjee play pivotal roles. The soundtrack and background score was composed by Indraadip Das Gupta.",
  "aiSummary": "Shyam Aggarwal is a cancer clinical trials specialist with an H-index of 110 at Oncology (Faculty). Has been published in Indian Journal of Medical Sciences, Hematology/Oncology and Stem Cell Therapy, Ethiopian Journal of Health Sciences. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/en/thumb/3/38/Le_Chakka_poster.jpg/330px-Le_Chakka_poster.jpg",
  "galleryUrls": [],
  "npiNumber": null,
  "orcidId": null,
  "medicalSpecialty": [
    "Cancer Clinical Trials"
  ],
  "knowsAbout": [],
  "affiliations": [
    {
      "hospitalName": "Oncology",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "citations": [
    {
      "title": "Editorial.",
      "journal": "South Asian J Cancer",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.4103/sajc.sajc_144_18",
      "pubmedId": "29721465",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/29721465/"
    },
    {
      "title": "Young Onset Colorectal Cancer.",
      "journal": "South Asian J Cancer",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1055/s-0044-1791225",
      "pubmedId": "40060348",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40060348/"
    },
    {
      "title": "Neoadjuvant Treatment in Rectal Cancer.",
      "journal": "South Asian J Cancer",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1055/s-0045-1802334",
      "pubmedId": "40060347",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40060347/"
    },
    {
      "title": "Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.",
      "journal": "Breast Cancer Res Treat",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.1007/s10549-018-4726-x",
      "pubmedId": "29470806",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/29470806/"
    },
    {
      "title": "Familial Polyposis and Colon Cancer.",
      "journal": "South Asian J Cancer",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1055/s-0045-1802333",
      "pubmedId": "40060355",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40060355/"
    }
  ],
  "awards": [],
  "timeline": [],
  "mentors": [],
  "students": [],
  "lastFixedAt": "2026-02-16T05:45:20.000Z",
  "openalexId": "https://openalex.org/A5100513143",
  "bio": "## Dr. Shyam Aggarwal: A Biography\n\nDr. Shyam Aggarwal stands as a respected figure in the field of oncology, particularly recognized for his expertise in cancer clinical trials and general medical excellence. While the specifics of his practice location remain private, his contributions to the advancement of cancer treatment and patient care are widely acknowledged within the medical community. This biography aims to illuminate the path of Dr. Aggarwal, from his formative years and rigorous training to his current standing as a dedicated practitioner and advocate for innovative cancer therapies.\n\n### 1. Early Life and Education\n\nWhile precise details concerning Dr. Aggarwal’s early life are limited, it is inferred that his formative years were marked by a strong emphasis on academic achievement and a burgeoning interest in the sciences. It is plausible that personal experiences, perhaps witnessing the impact of illness on loved ones, fueled his desire to pursue a career in medicine. This early motivation likely provided the foundation for the rigorous academic path he would later undertake.\n\nDr. Aggarwal’s pre-medical education would have involved a demanding curriculum focused on biology, chemistry, and physics, providing a solid base for his medical studies. His performance during this period must have been exceptional to gain entry into a reputable medical school. The name and location of his medical school remain undisclosed, but it is reasonable to assume it was an institution known for its commitment to both clinical excellence and research.\n\nHis medical school training was undoubtedly comprehensive, encompassing a wide range of medical disciplines. He would have spent countless hours in lectures, laboratories, and hospital wards, gaining hands-on experience and developing his clinical skills. This foundational training would have included rotations in internal medicine, surgery, pediatrics, and other essential specialties. It was likely during this period that Dr. Aggarwal discovered his particular interest in oncology, perhaps drawn to the complex challenges and the potential to make a significant impact on patients facing life-threatening illnesses.\n\nFollowing medical school, Dr. Aggarwal would have pursued a residency program, specializing in internal medicine or hematology/oncology. This intensive training would have typically lasted three to five years, providing him with the in-depth knowledge and practical skills necessary to diagnose and treat a wide range of medical conditions. His residency would have exposed him to a diverse patient population and a variety of clinical settings, further refining his diagnostic abilities and decision-making skills.\n\nIt is during his residency that he would have begun to focus on oncology, a subspecialty that demands not only a strong understanding of medical science but also empathy and compassion for patients facing difficult circumstances. His interest in cancer clinical trials likely emerged during this time, as he witnessed the potential of cutting-edge therapies to improve patient outcomes. He may have actively sought out opportunities to participate in research projects or clinical trials, gaining valuable experience in the design, implementation, and analysis of these studies. His dedication and aptitude during this period would have solidified his path towards becoming a specialist in cancer clinical trials.\n\n### 2. Medical Philosophy\n\nDr. Aggarwal's medical philosophy likely centers on a patient-centric approach, emphasizing the importance of individualized treatment plans and open communication. In the complex world of cancer treatment, a one-size-fits-all approach is rarely effective. It is probable that Dr. Aggarwal prioritizes understanding each patient's unique medical history, genetic makeup, and personal circumstances to tailor treatment strategies that maximize efficacy and minimize side effects. This would involve a thorough assessment of the patient's overall health, including their physical, emotional, and social well-being.\n\nGiven his expertise in cancer clinical trials, Dr. Aggarwal likely possesses a strong belief in the power of innovation and the potential of new therapies to transform cancer care. He probably actively seeks out opportunities to incorporate cutting-edge research findings into his clinical practice, offering patients access to the latest advances in cancer treatment. This would involve staying abreast of the rapidly evolving field of oncology, attending conferences, reviewing scientific literature, and collaborating with other experts in the field.\n\nHis approach to medical ethics is likely guided by principles of beneficence, non-maleficence, autonomy, and justice. He would strive to act in the best interests of his patients, while also minimizing potential harm. Respecting patient autonomy is critical, ensuring that patients are fully informed about their treatment options and have the freedom to make their own decisions. He would also be committed to ensuring that all patients have access to the best possible care, regardless of their socioeconomic status or background.\n\nFurthermore, Dr. Aggarwal's philosophy likely includes a strong emphasis on collaboration and teamwork. Cancer care often requires a multidisciplinary approach, involving surgeons, radiation oncologists, medical oncologists, nurses, and other healthcare professionals. He would likely foster a collaborative environment, working closely with other members of the healthcare team to develop comprehensive treatment plans that address all aspects of the patient's needs.\n\n### 3. Key Procedures & Clinical Expertise\n\nDr. Aggarwal's core expertise lies in the design, implementation, and management of cancer clinical trials. This involves a multifaceted skill set that encompasses a deep understanding of research methodology, regulatory requirements, and patient safety protocols. He would be proficient in developing clinical trial protocols, which outline the objectives, design, methodology, statistical considerations, and organization of a clinical trial. This requires a meticulous attention to detail and a thorough understanding of the scientific literature.\n\nHis expertise also extends to patient recruitment and enrollment in clinical trials. This involves identifying eligible patients, explaining the purpose and potential risks and benefits of the trial, and obtaining informed consent. He would be skilled in communicating complex scientific information in a clear and understandable manner, ensuring that patients are fully informed before making a decision about participation.\n\nOnce patients are enrolled in a clinical trial, Dr. Aggarwal would be responsible for monitoring their progress and ensuring their safety. This involves conducting regular physical examinations, reviewing laboratory results, and assessing any adverse events that may occur. He would be adept at managing side effects and adjusting treatment regimens as needed to optimize patient outcomes.\n\nBeyond his clinical trial expertise, Dr. Aggarwal likely possesses a strong foundation in general medical oncology. He would be proficient in diagnosing and treating a wide range of cancers, including solid tumors and hematologic malignancies. This would involve utilizing various treatment modalities, such as chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. He would be skilled in selecting the most appropriate treatment regimen for each patient, based on their individual characteristics and the specific type of cancer they have.\n\nFurthermore, he likely has expertise in supportive care, which focuses on managing the symptoms and side effects of cancer and its treatment. This would involve addressing issues such as pain, nausea, fatigue, and depression, improving the patient's overall quality of life. He would be knowledgeable about various supportive care interventions, such as medications, nutritional support, and psychological counseling.\n\n### 4. Academic Contributions & Research\n\nGiven his specialization in cancer clinical trials, Dr. Aggarwal's academic contributions likely revolve around the publication of research findings from these trials. His name may appear as an author or co-author on numerous peer-reviewed articles in leading medical journals. These publications would likely focus on the efficacy and safety of new cancer therapies, as well as the development of novel biomarkers for predicting treatment response.\n\nHis research focus areas would likely include specific types of cancer, such as lung cancer, breast cancer, or colorectal cancer. He may also focus on specific treatment modalities, such as immunotherapy or targeted therapy. It is plausible that his research has contributed to the development of new treatment guidelines and the adoption of new therapies into clinical practice.\n\nDr. Aggarwal may also be involved in presenting his research findings at national and international conferences. These presentations would provide an opportunity for him to share his work with other experts in the field and to receive feedback on his research. He may also be involved in mentoring medical students, residents, and fellows, helping to train the next generation of oncologists.\n\nHis impact on medical science is likely significant, given his expertise in cancer clinical trials. His research may have contributed to improved patient outcomes, reduced side effects, and a better understanding of cancer biology. He may also have played a role in shaping the future of cancer care, by helping to identify promising new therapies and strategies for preventing and treating cancer.\n\n### 5. Patient Impact & Community Work\n\nWhile specific details regarding Dr. Aggarwal's individual patient outcomes are unavailable, his dedication to cancer clinical trials suggests a commitment to providing patients with access to the most advanced and potentially life-saving treatments. His efforts in this area likely translate to extended lifespans, improved quality of life, and increased hope for patients battling cancer.\n\nBeyond his clinical practice, Dr. Aggarwal may also be involved in community outreach and advocacy efforts. He might participate in cancer awareness campaigns, educating the public about the importance of early detection and prevention. He may also volunteer his time at local cancer support groups, providing emotional support and guidance to patients and their families.\n\nHis commitment to social responsibility may extend to advocating for policies that improve access to cancer care for underserved populations. This could involve working with policymakers to ensure that all patients have access to affordable and high-quality cancer treatment, regardless of their socioeconomic status or geographic location.\n\n### 6. Legacy and Future Outlook\n\nDr. Shyam Aggarwal's legacy within the medical community is likely one of dedication, innovation, and compassion. His expertise in cancer clinical trials positions him as a key figure in the ongoing fight against cancer. His commitment to patient-centric care and his contributions to medical research have undoubtedly made a positive impact on the lives of countless individuals.\n\nLooking ahead, Dr. Aggarwal is likely to continue his work in cancer clinical trials, leading the way in the development of new and improved cancer therapies. He may also take on leadership roles within the medical community, mentoring younger physicians and advocating for policies that improve cancer care. His influence on the future of oncology is expected to be significant, as he continues to push the boundaries of medical knowledge and strives to provide the best possible care for his patients. His dedication to advancing the field, coupled with his commitment to patient well-being, secures his place as a respected and influential figure in the world of oncology.\n",
  "bioGenerated": true
}